Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/41236| metadata.artigo.dc.title: | Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19 |
| metadata.artigo.dc.creator: | Pindiprolu, Sai Kiran S. S. Pindiprolu, Sai Harshini |
| metadata.artigo.dc.subject: | COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Drug discovery Repurposing Niclosamide |
| metadata.artigo.dc.publisher: | Elsevier |
| metadata.artigo.dc.date.issued: | Jul-2020 |
| metadata.artigo.dc.identifier.citation: | PINDIPROLU, S. K. S. S.; PINDIPROLU, S. H. Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19. Medical Hypotheses, [S.l.], v. 140, July 2020. |
| metadata.artigo.dc.description.abstract: | Corona virus disease 2019 (COVID-19) pandemic caused 18 440 deaths world wide as of 25 March 2020 and posing a serious threat to public health. There is a need, therefore, for effective therapeutic strategies to cure this disease. However, high attrition rates, substantial costs and slow pace are the major limitations of novel drug discovery. Drug repurposing, by employing ‘old’ drugs to treat ‘new’ diseases is an attractive approach in drug discovery. Niclosamide (NIC) is an approved anti-helminthic drug with diverse antiviral mechanisms. In this work we hypothesize, the potential antiviral mechanisms of NIC against COVID-19. |
| metadata.artigo.dc.identifier.uri: | http://www.sciencedirect.com/science/article/pii/S0306987720305892 http://repositorio.ufla.br/jspui/handle/1/41236 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.